The Microlife WatchBP Home device demonstrated accuracy in pregnancy (mean difference 0.4/-0.4 mmHg) and preeclampsia (-2.6/0.8 mmHg), with 81% of women performing at least 6 measurements per day.
Observational (n=66)
Is the Microlife WatchBP Home device accurate and associated with good patient compliance for blood pressure monitoring in high-risk pregnancy?
The Microlife WatchBP Home device provides accurate blood pressure measurements in pregnancy and preeclampsia, with high patient compliance.
OBJECTIVE: To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy. METHODS: Device accuracy was assessed according to the British Hypertension Society protocol in 45 pregnant women, including 15 with preeclampsia. Twenty-one high-risk pregnant women used the device in addition to their antenatal care. RESULTS: The device achieved a mean difference +/- SD of 0.4 +/- 7.3/-0.4 +/- 5.5 mmHg (pregnancy) and -2.6 +/- 7.0/0.8 +/- 4.4 mmHg (preeclampsia) for systolic/diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week. CONCLUSION: The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
Chung et al. (2009) conducted an observational in High-risk pregnancy and preeclampsia (n=66). Microlife WatchBP Home blood pressure monitoring device was evaluated on Device accuracy (mean difference for systolic/diastolic pressure) and patient compliance. The Microlife WatchBP Home device demonstrated accuracy in pregnancy (mean difference 0.4/-0.4 mmHg) and preeclampsia (-2.6/0.8 mmHg), with 81% of women performing at least 6 measurements per day.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: